Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma

Eileen M. O'Reilly, Jonathan W. Lee, Maeve A. Lowery, Marinela Capanu, Zsofia K. Stadler, Malcolm J. Moore, Neesha Dhani, Hedy L. Kindler, Hayley Estrella, Hannah Maynard, Talia Golan, Amiel Segal, Erin E. Salo-Mullen, Kenneth H. Yu, Andrew S. Epstein, Michal Segal, Robin Brenner, Richard K. Do, Alice P. Chen, Laura H. Tang, David P. Kelsen
Wiley-Blackwell
Published 2018